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Abstract. This paper concerns detection of solid particles suspended in conductive media by 
impedance technique. The technique is based on changes in impedance measured between two 
electrodes placed across a given volume of conducting medium. It presents a methodology for 
modelling and investigation of the feasibility of such a technique for particle detection by 2D 
finite element (FE) field modelling. This is based on modelling and computation of electric 
field distribution between the above electrodes. It establishes the modelling approach, the 
complexity involved and justifies the need for modelling in 3D to incorporate some of the 
effects that cannot be taken into account in 2D models. It reports on the modelling 
investigation for a specific case of detecting, by impedance technique cholesterol particles 
suspended in human blood and points to a possible instrument for non-invasive measurement 
of blood cholesterol level. 
1.   Introduction 
Driven by concerns over public health associated with cardiovascular and other related diseases an 
easy, non-invasive, reliable and effective method for measuring cholesterol level in human blood is of 
increasing importance. There are at present a large number of direct and indirect methods that are 
available in clinical and research laboratories for the quantitative measurement of cholesterol in blood 
[1-3]. These measurements are being done increasingly frequently and often for prophylaxis and 
awareness against cardiovascular diseases. All these methods require a sample of the blood obtained 
from the body by an invasive procedure. The procedure may carry a risk of bruise, infection and/or 
hematoma. There are, however some indirect methods by which the level of total cholesterol can be 
estimated using bioelectrical impedance measurements carried out elsewhere in the body [4]. As these 
methods are indirect and based on inference of cholesterol level from statistical data obtained by 
multiple impedance measurements of substances other than blood, they are complicated, time 
consuming and often lack accuracy and reproducibility. 
Thus, there is a growing need to develop a simple, non-invasive method for measuring total blood 
cholesterol. It is proposed to do this by using electrical impedance technique in which the conductivity 
distribution of objects (e.g. cholesterol particles carried by lipoproteins) within a volume (e.g. blood 
plasma) is measured in the form of impedance (Z) between a pair of electrodes. The impedance 
technique has been widely used in many areas (industry, chemical production, pharmacy, medicine, 
biosciences) and it has been proven to be reliable for imaging (EIT, ERT) [5-7] and quantitative 
analyses (BMI, fuel purity, impedance spectroscopy) [8-11].  
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The impedance technique has been used successfully for many biological measurements of human 
body, especially for measuring characteristics of blood. These include measurement of body fluid 
volume [12], fat [13, 14], glucose [15], blood coagulation [16], hematocrit (erythrocyte volume 
fraction, EVF) [17], white blood cell count and other blood measurements [18]. However the blood 
measurement methods used involve an invasive procedure for obtaining blood from the body. 
As mentioned earlier, the proposed impedance technique for cholesterol measurement is non-
invasive and, in this paper the feasibility of this technique has been established by 2D finite element 
modelling.  This essentially comprises modelling of particles suspended in conductive media.  
2.  2D mathematical modelling of particles suspended in conductive medium and its finite 
element realisation 
2.1.  Mathematical model and impedance calculation 
Although the mathematical physics of conduction is well understood, the mathematics of describing 
the current and potential fields between and around impedance electrodes, particularly those attached 
to organic tissue, is more challenging. 
For given potentials ĳ assigned to driving electrodes the electric field distribution in the 2D 
problem domain  (x, y) between the electrodes is given by the following Laplace’s equation [19]: ׏ଶ߮ = 0 in  (1) 
Under appropriate boundary conditions the above equation is solved by finite element method 
(FEM) [20] in terms of unknown electric potential ĳ for given conductivity (ı) and permittivity (İ) 
distributions in the problem . It is assumed that the material properties are linear, piece-wise 
homogeneous and isotropic. Following the solution of equation (1), field intensity and flux density 
vectors E=–gradV (V is the potential difference between the driving electrodes) and D=İE can be 
calculated. From these the current I=JA (A is the cross-sectional area) is calculated using current 
density J= ıE. Finally, the impedance Z is calculated from the simple relationship between current (I) 
and voltage (V) between the electrodes: ܼ = ௏ூ  (2) 
For the modelling studies reported in this paper the above field equation was solved using the 
commercial software package COMSOL [21]. 
2.2.  Assumptions 
The modelling and computation of electric field distribution in the problem domain is based on a 
number of assumptions some of which are either justified by modelling experiments or discarded by 
introducing further complexities in the subsequent FE models. 
The main assumption taken in the studies reported here is that the electric field distribution 
between the driving electrodes mentioned above is two-dimensional and, it has been shown by 
modelling experiments that this is appropriate as a first approximation. 
The human blood is a complex medium, which is composed of cells of different sizes and shapes 
(red blood cells, white blood cells, platelets, etc.) distributed in a conductive aqueous solution (blood 
plasma). About 55% of the blood fluid is composed of blood plasma (mostly water – 91.5%) and the 
remaining 45% consists of various blood components (various blood cells and other inclusions) [22]. 
This means from the electric field and conductivity points of view blood is essentially a non-
homogenous and anisotropic medium. Specifically, this also means that the electrical properties of the 
whole blood (e.g. electrical conductivityı and the dielectric permittivity, İ are different from those 
of blood plasma, which contains no cells [23, 24]. 
For all modelling purposes it was assumed that blood was linear, piecewise homogeneous and 
isotropic. The piecewise homogeneity can account for non-homogeneous properties of blood and its 
isotropy is justified by the fact that in the 2D problem domain the main components of electric field 
IMEKO 2013 TC1 + TC7 + TC13 IOP Publishing
Journal of Physics: Conference Series 459 (2013) 012030 doi:10.1088/1742-6596/459/1/012030
2
(E, D) and current density vectors (J) are mainly confined in the x-y plane. Furthermore, it should be 
noted that for frequencies lower than 100 kHz most living tissues are assumed to be electrolytic 
conductors. At higher frequencies the dielectric properties of bio-tissue may dominate. The higher the 
frequency the closer the tissue properties come to those of water. 
There are no eddy current effects for the range of frequencies (50 Hz to 100 MHz) which is 
normally used for measuring impedance of living tissues. At higher frequencies electromagnetic 
properties of tissue become very close to the properties of water, so no useful information can be 
obtained. The lowest skin depth in this context is 30 mm (for blood plasma at 100 MHz), which is 
significantly higher than the characteristic size of features and problem domain involved. Hence there 
are no eddy-current effects. 
2.3.  Finite element models 
Figure 1 shows the basic 2D FE model of the problem domain  (x, y) in which Equation (1) was 
solved under the boundary conditions shown in Figure 2.  The active problem domain in between the 
driving electrodes is surrounded by air regions (ı  ı1) to account for any fringe and leakage fields. 
The blood-plasma region (ı  ı2) in between the electrodes is also extended in the y-direction to 
account for fringe field effects, which need to be quantified. As shown in Figure 1 the cholesterol 
particles (ı  ı3) are confined in the blood plasma between the electrodes.  
 
 
Figure 1. Basic 2D finite element (FE) model of particles in a conductive medium. 
 
 
Figure 2. 2D finite element model showing boundary conditions. 
 
The above FE models were used to investigate the effects of various parameters on the distribution 
of alternating currents and electric potential (hence voltage drops) in the problem domain. The 
parameters included various physiological (e.g. level and distribution of lipoproteins/cholesterol, other 
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blood components), material (e.g. dielectric permittivities (İ) and conductivities (ı) of blood 
components including lipoproteins carrying cholesterol particles). This can also be used to investigate 
the effects of electrical variables (e.g. measurement circuitry, excitation frequency, electrode geometry 
and their placement). Since the unknown potential distribution is a function of many of the 
physiological components in blood and tissue, the primary modelling aim here was to, by simulation 
establish an adequate and identifiable functional relationship between this distribution and the level of 
cholesterol in the blood. This would then provide a unique ‘impedance fingerprint’ corresponding to a 
given cholesterol level. 
2.4.  Inclusion of particles in the problem domain 
As mentioned before the human blood is a complex conductive medium. Fatty substances (lipids) are 
present in the plasma in suspension and in solution. Cholesterol, the particles used in this simulation 
study is almost insoluble in water (0.095 mg/l at 30 °C) and it is transported in the blood stream by 
lipoproteins (made up of proteins and lipids) that are water-dispersible and carry cholesterol and 
triglycerides internally. Based on the size, lipoproteins vary from chylomicrons (100-1000 nm in 
diameter), very low density lipoprotein (VLDL, 30-80 nm), intermediate density lipoprotein (IDL, 25-
50 nm), low density lipoprotein (LDL, 18-28 nm) and high density lipoprotein (HDL, 5-15 nm). LDL-
bound cholesterol is referred to as ‘bad cholesterol’ because high LDL level (in concentration and 
smaller particle size) is linked to cardiovascular diseases. On the other hand, HDL-bound cholesterol 
is often termed ‘good cholesterol’ because HDL can remove cholesterol from cells and atheroma and 
transport it back to the liver. Triglycerides, which form major components of VLDL and chylomicrons 
are also linked to cardiovascular diseases. Hence the Total cholesterol in the blood is defined as the 
sum of HDL, LDL, and VLDL. Given the wide variations in size and density of lipoproteins and the 
concentration of cholesterol they contain, it should be possible to measure by impedance technique not 
only the Total cholesterol but also its constituent components. Furthermore, these particles provide 
high contrast ratio in terms of electrical properties compared to other components in the blood. For 
example, because of different water content blood has a resistivity of about 1.6 ȍm, whereas fat has a 
resistivity of about 25 ȍm – 15 times higher than blood. Tissues other than those of heart and lungs 
have an approximate resistivity of 10 ȍm. 
From the modelling point of view it is important to note that total cholesterol of 5 mmol/l 
corresponds to about 1012 lipoprotein particles (5-30 nm in size) in each mm
3
 of blood. This clearly 
poses a major challenge for taking into account every individual particle for modelling purposes. This 
would not only introduce enormous complexity in building FE models but also dramatically increase 
modelling times to an unacceptable level. 
This problem was tackled by using a particle aggregation (coagulation) strategy in which smaller 
number of larger particles, Nc was used keeping the total volume of cholesterol particles, Vc, 
corresponding to a given blood cholesterol level constant. Knowing the total volume of cholesterol in 
1 mm
3 
of blood plasma, the total volume of cholesterol in the blood volume, Vb being modelled can be 
calculated. These parameters were then adjusted for FE models in two dimensions. However, this 
simplifying modelling strategy needed to be quantitatively justified by modelling experiments. This 
was to establish the maximum number of cholesterol particles above which no significant change in 
the modelling results could be obtained by further increasing the number of particles. Furthermore, the 
effects of randomness in the distribution (placement) of these Nc particles on modelling results also 
needed to be quantified. As it is evidenced from some of the modelling results given below in Section 
3 this strategy for particle aggregation (coagulation) simplifies FE models (Figure 3) without 
significantly affecting the results of FE modelling. Figure 4 shows typical FE discretisation used at the 
individual particle level. For simulation runs, the random distribution of particles in the active volume 
was achieved at the pre-processing stage by using appropriate Matlab scripts interfacing the FE 
software package COMSOL. This allowed automatic random generation and placement of particles in 
the problem domain for subsequent FE discretisation. 
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Figure 3. 2D FE models showing variable number of particles, Nc between the driving electrodes. 
 
 
Figure 4. Details of 2D finite element discretisation in and around a single particle. 
3.  Some of the modelling results and discussions 
3.1.  Comparison with simple analytical solutions 
To test the 2D FE models, a number of simple cases were tested for which accurate analytical 
solutions exist. Figure 5 shows the two cases in which 3 impedances are placed in series and in 









Figure 5. Simple series (above) and parallel (below) placement of impedances and their FE models. 
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shown in Figure 6 in which spherical particles are placed in series and in parallel with the driving 







Figure 6. Series (left) and parallel (right) arrangements of particles in FE models for comparison with 
simple analytical solutions. 
3.2.  Effects of the number of particles, Nc and their distribution 
For total volume of cholesterol particles, Vc corresponding to a given cholesterol level (3 mmol/l) the 
effects of particle numbers, Nc are shown in Figure 7. It shows that above a given threshold (Nc§200-
300, further refined to 500 by 3D modelling) no appreciable change in the modelling results can be 
obtained. This justified the particle aggregation strategy discussed in Section 2. 
 
Figure 7. Variation of modelling results with number of particles, Nc used in 2D FE modelling (total 




Figure 8. Effects of the distribution (placement) of particles on modelling results for 500 FE models 
containing randomly distributed particles (total number of particles, Nc=200=const.). 
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Figure 8 presents the effects of particle placement on modelling results which essentially shows 
that for a threshold number of particles, Nc the effects of placements of particles on modelling results 
average out to a clearly identifiable value corresponding to a given cholesterol level. 
The most important consequence of the above two graphs is that despite the enormous number of 
cholesterol particles in a given volume of blood there exists a much smaller threshold number of 
particles which is enough to simulate the effects of these larger number of particles. Furthermore, for 
this threshold number of particles the effects of their random distribution averages out. 
3.3.  Fringe field effects 
Figure 9 shows the fringe field effects at the edges of driving electrodes which justify the extension of 
problem domain beyond that bounded by the electrodes. This points to a need for 3D modelling since 
such effects are also present in the z-direction. The fringe field effects can be minimised in practice by 




Figure 9. Fringe field effects at the edges of driving electrodes for a given distribution of particles (the 
arrows represent current density vectors J). 
3.4.  Effects of cholesterol level 
The 2D FE modelling results presented in Figure 10 show that the impedance technique can be used to 
differentiate between different levels of cholesterol in the blood. However, they also point the need for 




Figure 10. Electrical ‘fingerprints’ corresponding to different cholesterol levels (total volume of 
particles, Vc=const. for a given cholesterol level) 
4.  Conclusions 
From the 2D modelling results presented this paper the following main conclusions can be made: (a) 
noninvasive impedance measurements can be used to differentiate between levels of Total cholesterol 
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in blood, (b) this is based on distinct electrical ‘fingerprints’ mentioned above, (c) detail 3D FE 
modelling is needed to take into account some of the electrical effects which cannot be seen in 2D. 
This work is on-going and the focus of the current research is to incorporate in the accurate 3D FE 
models major blood components and quantify their effects. 
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